Company profile
Serina Therapeutics, Inc.
AMEX:SERBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02579473 | phase1 | unknown | 2016-01-01 | 2023-12-31 | Serina Therapeutics | A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214 |
| NCT07422675 | phase1 | recruiting | 2026-02-01 | 2027-01-31 | Serina Therapeutics | SAD Study in Patients With Parkinson's Disease and Motor Fluctuations |
FDA applications (0)
No records yet.